Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

BACKGROUND: Clinical trials established the efficacy and safety of natalizumab. Data are needed over longer periods of time and in the clinical practice setting. OBJECTIVE: To evaluate long-term safety of natalizumab and its impact on annualised relapse rate and Expanded Disability Status Scale (EDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Butzkueven, Helmut, Kappos, Ludwig, Pellegrini, Fabio, Trojano, Maria, Wiendl, Heinz, Patel, Radhika N, Zhang, Annie, Hotermans, Christophe, Belachew, Shibeshih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215289/
https://www.ncbi.nlm.nih.gov/pubmed/24532785
http://dx.doi.org/10.1136/jnnp-2013-306936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215289/
https://www.ncbi.nlm.nih.gov/pubmed/24532785
http://dx.doi.org/10.1136/jnnp-2013-306936

Ejemplares similares